[PDF][PDF] The presence of staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis in own material

…, D Gawryluk, MM Martusewicz-Boros… - Clin Exp …, 2018 - clinexprheumatol.org
Objective. Nasal carriage of Staphylococcus aureus and its superantigens (SAg) seem to be
a risk factor disease exacerbation in granulomatosis with polyangiitis (GPA). We …

" The significance of cardiac magnetic resonance imaging in detection and monitoring of the treatment efficacy of heart involvement in eosinophilic granulomatosis …

…, U Nowicka, MM Martusewicz-Boros… - … Vasculitis, and Diffuse …, 2016 - europepmc.org
Background Cardiac magnetic resonance imaging (CMRI) has emerged as a sensitive and
non-invasive technique in the evaluation of cardiac lesions in eosinophilic granulomatosis …

Intratracheal dilation-injection technique in the treatment of granulomatosis with polyangiitis patients with subglottic stenosis

…, E Wiatr, D Gawryluk, MM Martusewicz-Boros… - The Journal of …, 2016 - jrheum.org
Objective. An analysis of subglottic stenosis (SGS) occurrence frequency in patients with
granulomatosis with polyangiitis (GPA) based on the time of appearance of clinical symptoms, …

Diagnostic and treatment standards in idiopathic pulmonary fibrosis in the era of antifibrotic drugs in Poland: a real-world practice survey

…, K Lewandowska, MM Martusewicz-Boros… - … in Respiratory Medicine, 2019 - mdpi.com
Introduction: Currently, only two drugs have been shown to modify the inevitable natural
history of idiopathic pulmonary fibrosis (IPF). Changes in the reimbursement policy for …

Diagnosis of sarcoidosis—the updated ATS 2020 recommendations through the prism of everyday clinical practice

MM Martusewicz-Boros… - Advances in Respiratory …, 2020 - journals.viamedica.pl
Diagnosis of sarcoidosis is not standardized, but there is a general consensus that it should
be based on the following criteria: consistent, adequate clinical presentation, demonstration …

[PDF][PDF] Progressive fibrosis in interstitial lung diseases—proposed definition and management

MM Martusewicz-Boros… - Advances in Respiratory …, 2021 - journals.viamedica.pl
Interstitial lung diseases may have an unpredictably progressive course, which is manifested
as progression of pulmonary fibrosis, causing an increasing impairment of lung function …

Cardiac sarcoidosis mimicking ischaemic infarct

MM Martusewicz-Boros… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Sarkoidoza jest systemową chorobą o nieznanej etiologii, zajmującą węzły chłonne i/lub
płuca, ale również inne narządy, w tym serce. Sarkoidoza serca (SS) może przebiegać …

[HTML][HTML] Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study

MM Martusewicz-Boros, PW Boros, E Wiatr, J Zych… - Medicine, 2019 - journals.lww.com
Dyspnea and exercise intolerance are usually attributed to pulmonary disease in sarcoidosis
patients. However, cardiac involvement may also be responsible for these symptoms. Data …

The role of intratracheal dilation–Injection technique in treatment of granulomatosis with polyangiitis (GPA) patients with subglottic stenosis

J Fijolek, E Wiatr, D Gawryluk, MM Martusewicz-Boros… - 2016 - Eur Respiratory Soc
OBJECTIVE: Analysis of occurence frequency of SGS in GPA patients, time of appearance
of clinical symptoms and assessement of effectivenes of treatment with particular taking into …

[PDF][PDF] Respiratory system involvement in chronic liver diseases

MM Martusewicz-Boros, PW Boros… - Pol Arch Med Wewn, 2013 - scholar.archive.org
Liver diseases are often associated with respiratory complications. They may manifest as
pleural effusion, interstitial lung disease, as well as various combinations of symptoms affecting …